The ROE as of September 2024 (TTM) for Ensysce Biosciences, Inc. (ENSC) is -705.90%

According to Ensysce Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -705.90%. This represents a change of -1811.26% compared to the average of 41.25% of the last 4 quarters.

Ensysce Biosciences, Inc. (ENSC) Historical ROE (quarterly & annually)

How has ENSC ROE performed in the past?

The mean historical ROE of Ensysce Biosciences, Inc. over the last ten years is 374.43%. The current -705.90% ROE has changed -288.53% with respect to the historical average. Over the past ten years (40 quarters), ENSC's ROE was at its highest in in the September 2021 quarter at 16.24%. The ROE was at its lowest in in the March 2023 quarter at -1096.56%.

Ensysce Biosciences, Inc. (ENSC) ROE by Quarter and Year

Discovering the peaks and valleys of Ensysce Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ensysce Biosciences, Inc. (ENSC) Average ROE

How has ENSC ROE performed in the past?

The current ROE of Ensysce Biosciences, Inc. (ENSC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ensysce Biosciences, Inc. (ENSC) ROE vs. Peers

How is ENSC’s ROE compared to its peers?

Ensysce Biosciences, Inc.’s ROE is greater than Zura Bio Limited (-35.45%), greater than Phio Pharmaceuticals Corp. (-142.68%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), less than 180 Life Sciences Corp. (3.04%), greater than Cardio Diagnostics Holdings, Inc. (-308.99%), greater than Virax Biolabs Group Limited (-115.10%), greater than Blue Water Vaccines, Inc. (-111.44%), greater than Revelation Biosciences, Inc. (-243.91%), greater than Hillstream BioPharma, Inc. (-47249.59%), less than Kiora Pharmaceuticals, Inc. (15.57%), greater than Quoin Pharmaceuticals, Ltd. (-112.11%), greater than Allarity Therapeutics, Inc. (-704.78%), less than Kiromic BioPharma, Inc. (337.72%), greater than Biodexa Pharmaceuticals Plc (-141.90%), greater than PaxMedica, Inc. Common Stock (-1151.68%),

Build a custom stock screener for Ensysce Biosciences, Inc. (ENSC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ensysce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ensysce Biosciences, Inc. (ENSC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ensysce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.